Paxirasol Egis supports melting mucus in respiratory diseases (20 tablets)

Dosage form Tablet
Specifications Box of 2 blisters x 10 tablets
Ingredient Bromhexine

Ingredient

Composition information	Content
Bromhexine	8mg

Uses

Indications

Paxirasol drugs are indicated for treatment in the following cases:

Acute or chronic respiratory diseases, such as bronchial asthma, bronchitis, bronchodilata accompanied by a secretion of mucus and solid and talks. In mucus cells, so that the acidic mucopolisaccharid fibers of bronchial secretions are more likely to disintegrate. The simultaneous activation of the fluid glands produces less mucus. In respiratory infections, bromhexine increases the production of active substances and has proven that the drug also increases the clearance of feathers in the mucosa.

pharmacokinetic

absorption

Bromhexine is well absorbed from the digestive tract and reaches the maximum plasma concentration within 1 hour after drinking.

Distribution

Bromhexine is attached to plasma proteins. According to animal studies, bromhexine passes through the placenta as well as being discharged into breast milk.

Metabolism

The active ingredient is metabolized in the liver (the transfer agent is ambroxol).

Elimination

Bromhexine is excreted in urine mainly in the form of metabolites (85-90%). The half -life of Hromhexine is about 6.5 hours.

kidney failure

The semi -cancellation time of bromhexine is longer in severe renal failure, so the dosage or medication distance must be reduced.

Before taking Paxirasol Egis supports melting mucus in respiratory diseases (20 tablets)

How to use

Should take medicine after serving with lots of water. Drinking a lot of water during treatment will make the mucus of bromhexine more easily.

Dosage

Adults

The usual dosage of the day for adults is 24 - 48 mg bromhexine: 1-2 tablets 3 times a day.

In case of bronchodilator can be used higher doses (48 mg - 2 tablets 3 times a day) in combination with antibiotics.

Children

Do not use paxirasol for children under 2 years old because of the safety and effectiveness of paxirasol for children under 2 years of age has not been determined.

Children from 2 to 6 years old: 12 mg daily (1/2 tablets 3 times a day).

Children from 6 to 14 years old: 24 mg per day (1 tablet 3 times a day).

Patients with liver failure

Do not change the dose when only liver failure, in patients with liver failure with kidney failure, the dose must be changed (see below).

Patients with renal failure

Must reduce the dose when severe renal failure or the distance to take the drug must be long.

Treatment time

Treatment time depends on the type, time or progress of symptoms.

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.

What to do when using overdose?

What to do when forgetting 1 dose? However, if the time to relax with the next dose is too short, skip the dose and continue the calendar of the drug. Do not use double dose to compensate for missed dose.

Side Effects

When using paxirasol often has unwanted effects (ADR) with the frequency defined as follows:

Very common: ≥ 1/10; Common: ≥ 1/100 to

Testing: It is impossible to estimate the frequency of existing data: temporarily increased SGOT and SGPT during treatment.

Nervous system:

Not common: dizziness, headache, weak people.

Digestive:

Not common: nausea, vomiting, epigastric pain, diarrhea.

The immune system:

Very rare: Symptoms may be allergic reactions: urticaria, swelling of the face, lips or tongue, difficulty swallowing, shortness of breath, angioedema or anaphylactic reaction.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

Contraindicated

Paxirasol drugs are contraindicated in the following cases:

Hypersensitivity to active ingredients (bromhexine, ambroxol) or any excipients of the drug.

Caution when using

while taking the drug must pay attention to the possibility of hypersensitivity reactions.

Paxirasol does not reduce dry cough directly.

Due to the risk of stagnation, when using paxirasol, it must be careful if there is a disorder in the movement of the bronchi or when the amount of secretion is high.

The effect of the drug on driving and operating machinery

has not encountered any cases that Bromhexine has affected the ability to drive and operate machinery.

Use drugs for women during pregnancy and nursing mothers

Clinical properties

In animal tests, it does not see the monster effect.

figures in human

Contraindicated to use paxirasol during pregnancy and during breastfeeding.

Medicinal interaction

should not be used simultaneously paxirasol with anti -cough drugs (such as codeine) because it can interfere with the expulsion of the phlegm that has been bromhexine melted.

When used in combination with some antibiotics (ampicillin, amoxicillin, cephalexin, erythromycin, oxytetracycline), bromhexine increases the penetration of antibiotics into the secretary of the bronchi.

Medication interactions can affect the activity of the drug or cause side effects.

Patients should notify the doctor or pharmacist a list of the drugs and functional foods you are using. Do not use or increase or decrease the dose of the drug without the guidance of a doctor.

Storage

Leave a cool place, avoid light, temperature below 30⁰C.

To be out of reach of children.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.